Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT07944768
NA

Optimal Induction Agent in Hemodynamically Unstable Patients Undergoing Emergency Surgery: A Comparative Study Between Ketamine and Etomidate With or Without Midazolam

Sponsor: Al-Azhar University

View on ClinicalTrials.gov

Summary

This work aimed to assess the hemodynamic effects of ketamine versus etomidate with or without midazolam as induction agents in patients undergoing emergency surgery.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

120

Start Date

2024-07-01

Completion Date

2025-02-01

Last Updated

2026-11-18

Healthy Volunteers

No

Interventions

DRUG

Ketamine

Patients received intravenous ketamine 2 mg/kg.

DRUG

Etomidate

Patients received etomidate 0.3 mg/kg.

DRUG

Ketamine + Midazolam

Patients received ketamine 1.5 mg/kg and midazolam 2 mg.

DRUG

Etomidate + Midazolam

Patients received etomidate 0.2 mg/kg and midazolam 2 mg.

Locations (1)

Al-Azhar University

Damietta, Egypt